Expression of a novel factor, com1, in early tumor progression of breast cancer

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1778-1783

  Ree, Anne Hansen ^a   Pacheco, Mercia M ^b   Tvermyr, Marianne ^a   Fodstad, Øystein ^a   Brentani, M Mitzi ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; TUMOR GROWTH;

ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BREAST NEOPLASMS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034075991     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A. General mechanisms of metastasis. Cancer (Phila.), 80: 1529-1537, 1997.
2. Reuning, U., Magdolen, V., Wilhelm, O., Fischer, K., Lutz, V., Graeff, H., and Schmitt, M. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis. Int. J. Oncol., 13: 893-906, 1998.
3. Uhr, J. W., Scheuermann, R. H., Street, N. E., and Vitetta, E. S. Cancer dormancy: opportunities for new therapeutic approaches. Nat. Med., 3: 505-509, 1997.
4. Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., and Groom, A. C. Multistep nature of metastatic inefficiency. Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol., 153: 865-873, 1998.
5. Ree, A. H., Tvermyr, M., Engebraaten, O., Rooman, M., Røsok, Ø., Hovig, E., Meza-Zepeda, L. A., Bruland, Ø. S., and Fodstad, Ø. Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res., 59: 4675-4680, 1999.
6. Andreasen, P. A., Kjøller, L., Christensen, L., and Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72: 1-22, 1997.
7. Ghiso, J. A. A., Alonso, D. F., Farías, E. F., Gomez, D. E., and de Kier Joffè, E. B. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem., 263: 295-304, 1999.
8. Schmitt, M., Harbeck, N., Thomssen, C., Wilhelm, O., Magdlen, V., Reuning, U., Ulm, K., Höfler, H., Jänicke, F., and Graeff, H. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb. Haemost., 78: 285-296, 1997.
9. Stephens, R. W., Brünner, N., Jänicke, F., and Schmitt, M. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer. Breast Cancer Res. Treat., 52: 99-111, 1998.
10. Kook, Y. H., Adamski, J., Zelent, A., and Ossowski, L. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J., 13: 3983-3991, 1994.
11. + RNA. Proc. Natl. Acad. Sci. USA, 81: 4727-4731, 1984.
12. Andreasen, P. A., Riccio, A., Welinder, K. G., Douglas, R., Sartorio, R., Nielsen, L. S., Oppenheimer, C., Blasi, F., and Dano, K. Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett., 209: 213-218, 1986.
13. Arnheim, N. Characterization of mouse ribosomal gene fragments purified by molecular cloning. Gene, 7: 83-96, 1979.
14. Vasseur, S., Mallo, G. V., Fiedler, F., Bödeker, H., Cánepa, E., Moreno, S., and Iovanna, J. L. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur. J. Biochem., 259: 670-675, 1999.
15. Muleris, M., Almeida, A., Gerbault-Seureau, M., Malfoy, B., and Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer, 10: 160-170, 1994.
16. Courjal, F., and Theillet, C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res., 57: 4368-4377, 1997.
17. Tirkkonen, M., Tanner, M., Karhu, R., Kallioniemi, A., Isola, J., and Kallioniemi, O. P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer, 21: 177-184, 1998.
18. Jänicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Höfler, H., and Graeff, H. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat., 24: 195-208, 1993.
19. Harbeck, N., Thommsen, C., Berger, U., Ulm, K., Kates, R. E., Höfler, H., Jänicke, F., Graeff, H., and Schmitt, M. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Breast Cancer Res. Treat., 54: 147-157, 1999.
20. Schmitt, M., Thomssen, C., Ulm, K., Seiderer, A., Harbeck, N., Höfler, H., Jänicke, F., and Graeff, H. Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer. Br. J. Cancer, 76: 306-311, 1997.
21. Altman, D. G., and Lyman, G. H. Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res. Treat., 52: 289-303, 1998.
22. Pacheco, M. M., Brentani, M. M., Franco, E. L., Fontelles, J. A., Chamone, D. F., and Marques, L. A. Plasminogen activator expression and steroid hormone receptors in female breast cancer: a multifactorial study. Int. J. Cancer, 41: 798-804, 1988.